SCHEMBL5374495

SCHEMBL5374495

NC(=O)c1cc(N2CCCCC2Cc2ccccc2)c2ccn(C(=O)c3cccnc3)c2c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.42
NAMPT P43490 1/20 0.37
DAGLB Q8NCG7 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 3/20 0.36
HPGD P15428 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
PARP14 Q460N5 1/20 0.36
CHRM2 P08172 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
CDC42BPB Q9Y5S2 1/20 0.35
MAPT P10636 1/20 0.34
HCRTR1 O43613 1/20 0.34
HCRTR2 O43614 1/20 0.34
CYP3A4 P08684 1/20 0.34
VNN1 O95497 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5376315 0.74 SLC6A4 (0.43) PARP14ROCK2ROCK1CDC42BPBSLC6A4
SCHEMBL1062867 0.69 CYP2C9 (0.50) MEN1KMT2ACHRM2SMN1; SMN2PKM
SCHEMBL5374499 0.67 MEN1 (0.41) MEN1KMT2ACHRM2SMN1; SMN2PKM
SCHEMBL3490535 0.66 CYP2C9 (0.48) MEN1KMT2ACHRM2SMN1; SMN2PKM
SCHEMBL18043464 0.61 HCRTR1 (0.37) DAGLBALDH1A1MEN1KMT2APARP14
SCHEMBL14559843 0.61 MGLL (0.53) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL17600733 0.60 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL17600730 0.60 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL30589318 0.60 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL18353956 0.60 GBA1 (1.00) GBA1ALDH1A1HPGDMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed